T A B L E O F C O N T E N

Objectives
To assess the effects of reminder systems and late patient tracers on completion of diagnostics, commencement of treatment in people referred for curative or prophylactic treatment of tuberculosis, completion of treatment in people starting curative or prophylactic treatment for tuberculosis, and cure in people being treated for active tuberculosis.
Search strategy
We Tuberculosis (1983 to June 2008 , and reference lists. We also contacted researchers working in the field.
Selection criteria
Randomized controlled trials (RCTs), including cluster RCTs and quasi-RCTs, and controlled before-and-after studies comparing any reminders or late patient tracers with no or other kinds of reminders or late patient tracers. We included people in any setting who require treatment for tuberculosis or require prophylaxis against tuberculosis and are referred to tuberculosis diagnostic or screening services.
Data collection and analysis
Two authors independently assessed trial risk of bias and extracted data. No meta-analysis could be undertaken due to the heterogeneity of interventions across trials.
Main results
Nine trials involving 5257 participants met the inclusion criteria. Three assessed the use of late patient tracers, and six assessed reminder systems. Late patient tracers (home visit and letter) were shown to be beneficial in increasing adherence to tuberculosis treatment compared with no late patient tracer. The results from almost all the reminder trials, except one, show benefits of different types of reminders compared to no reminder on adherence to tuberculosis clinic appointments.
Authors' conclusions
The included trials show significantly better outcomes among those tuberculosis patients for which late patient tracers and reminders are used. Studies of good quality (large and with rigorous study design) are needed to decide the most effective late patient tracer actions and reminders in different settings. Future studies of reminders in chemoprophylaxis and treatment settings would be useful.
P L A I N L A N G U A G E S U M M A R Y
Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
This review aimed to assess the effects of reminder systems and late patient tracers on patients' adherence to medical advice (such as attending clinic appointments for taking anti-tuberculosis drugs) and on clinical outcomes (such as cure of tuberculosis) in the following situations: treatment for active tuberculosis; tests for diagnosis of tuberculosis; and treatment to prevent tuberculosis in high-risk individuals. Reminder systems are used before a clinic or drug-collection appointment to remind patients to attend the appointment, or sometimes during treatment at home to remind patients to take their drugs. Late patient tracers are similar interventions undertaken when patients fail to keep an appointment to encourage them to return to treatment. The review found nine trials involving 5257 participants. Six trials assessed reminder systems and three trials assessed the use of late patient tracers. The results from five of the six reminder trials showed benefits. Trials of late patient tracers (home visits and letters) also showed benefits of the intervention in increasing adherence to tuberculosis treatment. Hence, overall, the results showed better outcomes among those patients for whom reminders or late patient tracers were used.
B A C K G R O U N D Prevalence of tuberculosis
Tuberculosis is a growing international health concern. As a cause of human suffering, death, and impoverishment, tuberculosis ranks among the leading infectious diseases. About two billion people, or nearly one-third of the world's population, are thought to be infected with Mycobacterium tuberculosis. There were almost 8.8 million new cases of active tuberculosis in 2005, and there are an estimated 1.6 million deaths from tuberculosis each year ( WHO 2007).
Diagnosis and treatment
Methods of tuberculosis diagnosis vary depending on the infection, site, patient age, availability of facilities, and local policy. The standard method of diagnosis for active pulmonary tuberculosis is sputum microscopy, where people provide two or three sputum samples, including an early morning sample, collected on separate occasions. Sputum culture is also used; this detects more cases but takes longer for the results to become available. Patients are advised to return to the clinic to receive the results, while those with positive results are usually referred for treatment. Those with negative sputum smear results may undergo further investigation for tuberculosis, may need to return for the results of sputum culture tests, or both. In some countries, groups considered to be at high risk may be screened for tuberculosis infection (active or latent) using Purified Protein Derivative (PPD) tests (also known as tuberculin skin test), such as Mantoux or Heaf tests, or the more recently devel-oped interferon-gamma blood tests. PPD tests involve injecting a protein derivative of the M. tuberculosis bacillus into the skin, waiting 48 to 72 hours, and then measuring any localized swelling (or induration) of the skin around the injection site. People with positive results may then undergo further tests to detect or exclude active tuberculosis, followed by treatment for active cases and prophylaxis for latent infection. In this review, we consider 'prophylaxis' to mean drug prophylaxis. Prophylaxis in this case refers to measures to prevent progression from infection to disease through the administration of antituberculous drugs. To be successful, the processes of screening, diagnosis, and treatment require all patients to attend several healthcare appointments (or contacts with healthcare staff ). Unless direct observation of therapy is used, treatment for active or latent tuberculosis also requires patients to take regular self-administered medication. To cure tuberculosis with the standard regimen, the World Health Organization (WHO) recommends that at least 75% of the prescribed drugs must be taken, and, if treatment is interrupted, it must be interrupted for less than two months (WHO 2003a).
Adherence
Adherence is defined as the extent to which a person's behaviour corresponds with agreed recommendations from a healthcare provider (WHO 2003b) . In the case of tuberculosis, this may be defined as the extent to which the patient's history of therapeutic drug-taking coincides with prescribed treatment. This may be using outcome-oriented definitions such as cure rate, or processrelated definitions such as appointment-keeping or pill counts ( WHO 2003b ). More recently the term 'concordance' has come into use; this refers to a consensual agreement about treatment, established between patient and practitioner. In the context of this review, the two terms are interchangeable, as patients' attendance at appointments relates to both concepts (Haynes 2008) . Poor adherence to antituberculous treatment may lead to treatment failure and relapse (Ormerod 1991), drug resistance (Weis 1994; Mitchison 1998) , and prolonged and expensive therapy that is less likely to be successful than the treatment of drug-susceptible tuberculosis (Goble 1993) . Poor adherence also results in increased transmission rates of the tubercle bacilli, morbidity, and cost to the tuberculosis control programmes (Johansson 1999) . The WHO estimates that 60% of sputum smear-positive tuberculosis cases were detected globally in 2005 (WHO 2007), 10% below the 70% target. It is not known how many patients are lost to follow up during the process of conducting various laboratory tests (eg sputum acid-fast bacilli smears taken two to three times) to confirm the tuberculosis diagnosis. Globally, treatment success rates for tuberculosis since 1998 have been close to, but persistently below, the 85% target set by the WHO (WHO 2006) . This gap is due not only to the high rates of death among people living with HIV/AIDS but also to high rates of treatment interruption and transfer. Also, several regions of the world are experiencing unprecedented increases in the prevalence of multiple-drug-resistant (MDR) tuberculosis, which threatens tuberculosis control and translates into low cure rates. The WHO reports that the estimated incidence in 2006 was 489,139 globally, with the proportion of MDR tuberculosis at 4.8% (95% CI 4.6 to 6.0) (WHO 2008) . There is also the severe threat of extensively drug-resistant (XDR) tuberculosis, which has an extremely high mortality rate. Adherence to a tuberculosis treatment programme requires accessible and appropriate health care, and a number of interventions have been used to promote adherence (WHO 2003b) . This Cochrane Review is one of several planned or in progress to evaluate each type of intervention:
• Reminder systems and late patient tracers in the diagnosis and management of tuberculosis: routinely reminding patients to keep an appointment and actions taken when patients fail to keep an appointment (this review).
• Staff motivation and supervision: training and management processes that aim to improve how providers care for people with tuberculosis.
• Education and counselling for promoting adherence to the treatment of active tuberculosis: provision of information or oneto-one or group counselling about tuberculosis and the need to attend for treatment (M'Imunya 2007) .
• Incentives and reimbursements: money or cash in kind to reimburse expenses of attending services, or to improve the attractiveness of visiting the service.
• Contracts: written or verbal agreements to return for an appointment or course of treatment (Bosch Capblanch 2007) .
• Peer assistance: people from the same social group helping someone with tuberculosis return to the health service by prompting or accompanying them.
• Directly observed therapy (DOT): an appointed agent (health worker, community volunteer, family member) directly monitors people swallowing their antituberculous drugs ( Volmink 2007).
It has long been accepted that the best way to improve adherence to long-term treatment regimens is extended supervision of and contact with patients (Haynes 2008) . This review assesses the effectiveness in improving adherence with respect to two types of interventions to maintain contact with patients using diagnostic and treatment services.
Reminder systems and late patient tracers
In this review, a reminder is defined as any action to contact patients shortly before they are due to take their medication or attend a healthcare appointment for tuberculosis diagnosis or treatment, and to remind them to take their medication or attend their appointment, to ensure adherence. Late patient tracers (sometimes called 'defaulter actions') are undertaken when patients fail to keep an appointment, generally to attempt to make contact with the patient, sometimes to find out why they did not attend, and to help patients understand the need to attend treatment and overcome barriers to attending for treatment. The type of reminders and late patient tracers could be visits made to patients or contacts by health workers, letters, telephone calls (Thilakavathi 1993), and more recently, e-mails and SMS text messages (Green 2003) . Reminders and late patient tracers may be undertaken by health service staff, volunteers, or community members. They might often include a health education component, explaining to the patient why they need to attend appointments and take their medication. Reminders and late patient tracers are not newly developed interventions, and some national treatment programmes use one or both as standard procedure. For example, in 1988 to 1989, the National Treatment Program Manuals in India recommended late patient tracers to contact patients who did not return to the clinic for their fortnightly drug collection, on the first day after a missed appointment and then on the fourth day (Jagota 1996). In Malaysia, where DOT is used, when patients have missed more than seven consecutive days of treatment, a specialist late patient tracing team visits their home to find out why they have not attended the clinic for treatment. Another visit is made if the patient subsequently fails to attend (O'Boyle 2002) . Reminder systems and late patient tracers as strategies to improve patients' adherence to tuberculosis screening, diagnosis, and treatment have not been reviewed systematically before. This review seeks to fill the gap in evidence, and highlight where more research might be needed.
O B J E C T I V E S
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Randomized controlled trials (RCTs) including cluster RCTs and quasi-RCTs.
• Controlled before-and-after studies (CBAs).
Types of participants
• Children and adults in any setting who require treatment for tuberculosis. This includes people with pulmonary tuberculosis (diagnosed by sputum microscopy, culture, or both, regardless of HIV status), smear-negative pulmonary tuberculosis (diagnosed by symptoms and chest radiograph findings or other diagnostic tests, regardless of HIV status), or extrapulmonary tuberculosis (diagnosed by signs or symptoms and histopathology, sputum acid-fast bacilli smear, culture, or both, imaging studies or polymerase chain reaction (PCR)).
• Children and adults in any setting with tuberculosis infection who require prophylaxis against tuberculosis.
• Children and adults in any setting referred (including selfreferred) to tuberculosis diagnostic or screening services.
Types of interventions
Interventions
• Any actions taken to remind patients to take their tuberculosis medication or attend appointments (reminders) .
• Any actions to contact patients who have missed an appointment (late patient tracers).
Controls
• No reminders or late patient tracers.
• Other kinds of reminder actions or other interventions to improve adherence.
• Other kinds of late patient tracers or other interventions to improve adherence.
Types of outcome measures
Primary
• Completion of tuberculosis diagnostics.
• Completion of screening process.
• Commencement of prophylactic treatment.
• Commencement of curative treatment.
• Completion of prophylactic treatment.
• Completion of curative treatment.
• Cure.
• Incidence of active tuberculosis (in studies of prophylactic treatment).
Secondary
• Any measure of adherence to treatment or attendance at appointments.
• Any measure of patient involvement or patient satisfaction.
• Any adverse event (eg elevated liver enzymes, optic neuritis).
Search methods for identification of studies
We attempted to identify all relevant studies regardless of language or publication status (published, unpublished, in press, and in progress).
Databases
We searched the following databases using the search terms and strategy described in 
Researchers and organizations
For unpublished and ongoing trials, we contacted study authors and other researchers working in the field and the following organizations: World Health Organization (WHO); the Tuberculosis Trials Consortium (TBTC); the International Union against TB and Lung Diseases (IUATLD); the European Developing Countries Clinical Trials Programme (EDCTP); and the Global Partnership to Stop TB.
Non-indexed journals
We searched the online Indian Journal of Tuberculosis from 1983 to June 2008 using 'tuberculosis' and '(reminder OR compliance)' as search terms.
Reference lists
We also checked the reference lists of all studies identified by the above methods.
Data collection and analysis
Selection of studies K Abba and MA Lansang independently applied the inclusion criteria to all identified trials, and screened all citations and abstracts identified by the search strategy to exclude trials that clearly did not meet the inclusion criteria. If either of them judged that the trial might be eligible for inclusion, we obtained the full paper. After obtaining full reports of all potentially eligible studies, K Abba and V Balanag assessed these for inclusion in the review using a pre-designed eligibility form based on the inclusion criteria and resolved any disagreements by discussion with a third author (Q Liu). We also scrutinized publications to ensure that each trial was included only once.
Data extraction and management
Two authors from each team (M Alejandria and R Berba for reminders, Q Liu and V Balanag for late patient tracers) independently extracted the data using a tailored data extraction form. We extracted data on study design, methods, participant characteristics, interventions, and outcomes. For dichotomous data, we extracted the number of events of interest, the total number randomized to each group, and the total number analysed. For continuous data, we extracted the number of participants randomized, the number analysed, and the number of participants in each group; and also the arithmetic means and their standard deviations for some variables. Study authors were contacted to supply missing information and to clarify issues. We resolved discrepancies by discussion.
Assessment of risk of bias in included studies
Papers selected for inclusion were divided between two teams of review authors according to the type of intervention assessed (reminders or patient tracing). Two authors in each team independently assessed the risk of bias of the included trials. M Alejandria and R Berba for reminders; and Q Liu and V Balanag for patient tracing. For RCTs and quasi-RCTs, we assessed the generation of the allocation sequence and allocation concealment as adequate, inadequate, or unclear according to Jüni 2001. We reported who was blinded in each trial and classified blinding as yes, no, not possible, and unclear for providers, participants, and assessors, respectively. We assessed the inclusion of randomized participants in the analysis as adequate if 80% or more, unclear if not described, and inadequate if less than 80%. We also assessed protection against contamination as 'done' if allocation was by community, institution, or practice and it was unlikely that the control group received the intervention, 'unclear' if providers were allocated within a clinic or practice and communication between experimental and group providers was likely to occur, and 'not done' if it was likely that the control group received the intervention. We used a pro-forma to guide the assessment of risk of bias. We also contacted the study authors when essential information to judge quality was missing. Any disagreements were resolved by discussion and by consulting a third author (MA Lansang for reminders and V Balanag for late patient tracers) when necessary.
Data synthesis
Q Liu undertook the analysis using Review Manager 5 in consultation with the other authors. We did not pool results statistically because of heterogeneity across the type of interventions, study design, settings, and outcomes. We stratified the analysis by the indication for the intervention (screening, prophylaxis, and treatment), type of reminder or late patient tracer, and study design. Risk ratios (RR) and 95% confidence intervals (CI) were used for dichotomous data with an available-case analysis. We will use the methods outlined in the protocol to handle other types of data (eg continuous data or analysis of cluster trials or controlled beforeand-after studies) in future updates. We tested for heterogeneity using the Chi 2 test for heterogeneity with a cut-off of P < 0.10 and the I 2 test, with > 50% indicating significant heterogeneity. We did not combine trials even by the random-effects model because of the significant heterogeneity. The results were presented as forest plots without subtotals and risk ratio calculations. We will use the methods outlined in the protocol for subgroup and sensitivity analyses in future updates.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies.
Nine studies involving 5257 participants met the inclusion criteria (see 'Characteristics of included studies'). Seven were RCTs and two were quasi-RCTs. Two were reported in one article (Roberts 1983i; Roberts 1983ii) . Twelve studies that initially seemed to fit the inclusion criteria were eventually excluded for the reasons given in the 'Characteristics of excluded studies'.
Type of intervention Late patient tracers
Three individually RCTs were included (Krishnaswami 1981; Paramasivan 1993; Mohan 2003) . Krishnaswami 1981 compared the effectiveness of two kinds of late patient tracers, a home visit and if necessary up to another three visits compared with a reminder letter the first time and if necessary a home visit once. Paramasivan 1993 and Mohan 2003 compared reminder letters or routine home visiting for patients missing an appointment with a control group without late patient tracers.
Reminder systems
Two individually quasi-RCTs (Tanke 1994; Cheng 1997) and four individually RCTs were included (Roberts 1983i; Roberts 1983ii; Sanmarti 1993; Tanke 1997) . Two of the trials were carried out at the same time and location, and reported in the same article (Roberts 1983i; Roberts 1983ii), but they were separate experiments with different participants and interventions. Roberts 1983i compared eight groups receiving four types of return reminders, including postcard, telephone call, direct person-to-person, and take-home card in combination with two types of authority sources (experts and non-experts). Roberts 1983ii compared 12 groups receiving a combination of two types of message on the importance of returning (enhanced versus standard), two types of reminders (take-home card versus no reminder card), and three types of overt commitment to return (verbal, verbal plus written agreement, or no commitment). Except for Tanke 1997, which compared a pre-recorded telephone reminder message (TeleMinder system) twice with no reminder message, the trials all had more than one intervention arm. Cheng 1997 applied five types of intervention for following up the tuberculosis test reading, of which the intervention of interest for this review was the reminder phone call in group 2. Tanke 1994 compared no message with four types of automated telephone reminders (basic reminder, basic reminder plus authority endorsement, basic reminder plus importance statement, and basic reminder plus importance statement plus authority endorsement) for patients scheduled for three different clinic appointments. Sanmarti 1993 compared three types of intervention with a control; the interventions in groups one and two (telephone call reminder and home visit by specialized nursing personnel) met our inclusion criteria.
Countries
Of the trials assessing late patient tracers, two were carried out in India (Krishnaswami 1981; Paramasivan 1993) and one in Iraq ( Mohan 2003) . Most of the trials assessing reminders were carried out in the USA (Roberts 1983i; Roberts 1983ii; Tanke 1994; Cheng 1997; Tanke 1997) , except one trial carried out in Spain ( Sanmarti 1993).
Participants
All three trials of late patient tracers were conducted among patients undergoing treatment for active tuberculosis. Krishnaswami 1981 included patients aged 12 years or more with radiographic evidence of tuberculosis but negative smears, Paramasivan 1993 studied newly diagnosed adult sputum smear-positive pulmonary tuberculosis patients, while Mohan 2003 studied new smear-positive PTB patients. For reminders, four trials assessed the effectiveness of different reminders on the tuberculin skin test return of different groups of people (Roberts 1983i; Roberts 1983ii; Cheng 1997; Tanke 1997) . Cheng 1997 studied children aged 1 to 12 years; Tanke 1997 studied persons of different ages (< 5 years, 5 to 12 years, 13 to 19 years, 20 to 29 years, and > 29 years); and Roberts 1983i/ Roberts 1983ii studied college students who were volunteers in a university-sponsored tuberculosis detection drive. One of the included trials was conducted in primary school children undergoing tuberculosis chemoprophylaxis (Sanmarti 1993) , and the remaining trial was done in a wide range of age groups receiving tuberculosis diagnosis, tuberculosis chemoprophylaxis, or treatment (Tanke 1994).
Setting
All three late patient tracer trials were performed in clinics ( Krishnaswami 1981; Paramasivan 1993; Mohan 2003) . The six reminder trials were performed in different settings, including a children's national medical centre (Cheng 1997), clinics (Tanke 1994; Tanke 1997), a primary school (Sanmarti 1993), and a university (Roberts 1983i; Roberts 1983ii) .
Outcomes
Based on the outcomes defined in the protocol, the main outcome assessed in the late patient tracer trials was the number of patients who did not complete treatment. For reminders, the number of patients who did not adhere to a scheduled appointment was the main outcome assessed in the included trials.
Risk of bias in included studies
Our assessment of risk of bias is summarized in Table 2 with individual trial details provided in the 'Characteristics of included studies'. 
Late patient tracers
All three trials of late patient tracers used a RCT study design. In both Paramasivan 1993 and Mohan 2003, the generation of the allocation sequence and allocation concealment were adequate, and protection against contamination was also present; while in Krishnaswami 1981, allocation generation, allocation concealment, and protection against contamination were not clearly documented.
In all three trials, inclusion of randomized participants in the analysis was assessed as adequate, that is, over 80% of participants who were randomized in groups were included in the analysis.
Only Mohan 2003 clearly documented blinded assessment of the primary outcomes. Paramasivan 1993 did not blind outcome assessors and Krishnaswami 1981 did not explicitly state this.
Reminders
Two trials used a quasi-RCT design (Tanke 1994; Cheng 1997) , and the remaining four trials used a RCT study design (Roberts 1983i; Roberts 1983ii; Sanmarti 1993; Tanke 1997) . Cheng 1997 allocated by day of the week; for Tanke 1994, within each fiveweek period each message variation was used once on each weekday and different variations were used each day of a given week by a computer-generated system. The allocation generation in four RCTs was not clearly documented. Of all the included studies on reminders, concealment of allocation and protection against contamination were not clearly documented, while the inclusion of randomized participants in the analysis was adequate. None of the trials clearly documented blinded assessment of the primary outcomes.
Effects of interventions 1. Late patient tracers
Three trials assessed the use of late patient tracers, and each compared different types (eg letters or home visits). One trial also included health education with the late patient tracers.
Letter versus no late patient tracer
Paramasivan 1993 compared posting of letters reminding patients who did not collect their medication within three days of the due date to attend and collect their medication with no late patient tracers. Sixty pulmonary tuberculosis patients out of the 200 enrolled were late patients in this study. Fewer patients in the intervention group (12%) did not complete treatment compared with the control group (27%) (RR 0.44, 95% CI 0.24 to 0.83; 200 participants, Figure 1 , Analysis 1.1). Eleven out of 23 patients in the intervention group who missed their first appointment failed to return to treatment, compared with 26 out of 29 in the control group (RR 0.53, 95% CI 0.34 to 0.83; 52 participants, Analysis 1.2). This trial also found that treatment default, which was defined by the trial as failing to collect the drugs within three days after the due date of drug collection, was high among illiterate patients but retrieval rate among them was also high in the intervention group. 
Home visit versus letter
In Krishnaswami 1981, patients who failed to collect their drugs on the due date received either a home visit and, if necessary, another three visits, or a reminder letter the first time and, if necessary, one home visit. In total, 170 patients were admitted to the study, 150 of which were included in the main analysis; of these 121 were late patients. There was no significant difference between patients who received home visits and those who received reminder letters in the number of patients who did not complete treatment (150 participants, 1 trial, Figure 2 , Analysis 3.1) or retrievals after the first action for first episode of default (121 participants, 1 trial, Analysis 3.2). However, the mean number of drug collections for one year was reported as significantly higher in the home visit group than in the reminder letter group (9.8 versus 8.6, P = 0.03). We were not able to calculate the mean difference and confidence interval as standard deviations were not provided.
Figure 2. Late patient tracers (home visit) vs letter: Patients who did not complete treatment
Two participants withdrew from the study because of adverse effects of the medication used (thioacetazone). Both patients were in the group receiving the less intensive follow up (letter plus one home visit if necessary) upon missed appointments.
Reminders
Automated telephone reminders versus no reminder
Tanke 1997 evaluated the effectiveness of automated telephone reminders on tuberculin skin test return in both children and adults. The trial authors did not present the data that would enable us to calculate risk ratios and confidence intervals (requested data from trial authors and awaiting reply). However, they reported a significantly positive effect of automated telephone reminders (7% failed to return) on return for skin test reading compared to no reminder message (12% failed to return), with an odds ratio of 1.71 (P < 0.05). Tanke 1994 compared four different automated telephone reminders in patients attending three different tuberculosis clinics with no reminders. Patients in this study were scheduled for appointments at clinics for diagnosis, prophylaxis, and treatment. Those receiving reminders were significantly more likely than those not receiving reminders to attend their appointments in prophylaxis clinics (RR 0.72, 95% CI 0.58 to 0.89; 536 participants, Figure 3 , Analysis 4.1) and treatment clinics (RR 0.69, 95% CI 0.56 to 0.86; 597 participants, Analysis 4.1), but there was no significant difference between the groups in diagnosis clinics (RR 0.94, 95% CI 0.79 to 1.12; 857 participants, Analysis 4.1). There were no significant differences in the effects of different kinds of messages (Analysis 4.1). Cheng 1997 compared the effectiveness of a reminder phone call to parents of children aged one to 12 years on attendance for Mantoux test reading with no reminder. Fewer children whose parents received the reminder call failed to return for Mantoux test reading (RR 0.70, 95% CI 0.50 to 0.99; 246 participants, Analysis 5.1).
Reminder plus health education versus usual care
Sanmarti 1993 evaluated a telephone call reminder and home visit by specialized nursing personnel every three months on the adherence to tuberculosis chemoprophylaxis in school children. The data on attendance at the last visit showed that both a telephone call reminder (RR 0.18, 95% CI 0.07 to 0.44; 157 participants) and home visit reminder (RR 0.14, 95% CI 0.05 to 0.39; 156 participants) significantly improved the attendance at the final appointment compared with the control group; see Figure 4 and Analysis 6.1. 
Comparisons of various reminder formats
Two trials were reported in one article; both were experiments with a factorial design in volunteers (mainly college students). The first experiment assessed four methods of providing return reminders (postcard, telephone call, direct person-to-person, or take-home card) in combination with two types of authority sources (expert versus non-expert) (Roberts 1983i) . The data on return showed no significant difference in non-attendance at clinic appointments between participants who received reminders from experts and those who received reminders from non-experts (200 participants, Analysis 7.1), or between reminders delivered as a take-home card, a postcard, a telephone call, or person-to-person message (Analysis 7.1). The second experiment assessed combinations of types of patient commitment (verbal, verbal plus written, or no commitment) with importance-of-returning message (enhanced versus standard) as well as with two types of return reminders (take-home card versus no reminder) (Roberts 1983ii). The return rate for participants who received take-home card reminders was 70.9% while the return rate for those who received no reminders was 72.0%, which showed no difference in non-attendance to clinic appointments between reminder group and control group (553 participants, Analysis 7.2).
D I S C U S S I O N
Nine trials, reported in eight papers, were included in this review. Three assessed the use of late patient tracers and the other six assessed reminder systems.
For late patient tracers, two RCTs carried out in India and Iraq compared late patient tracer actions (letters and home visits, respectively) with usual care in people being treated for tuberculosis. Another RCT, also carried out in India, compared letters with home visits. The size of trials was relatively small, ranging from around 80 to 240 participants in each group, while the risk of bias in the trials varied; generation of allocation sequence and allocation concealment were not clear in one trial, while the other two trials had adequate allocation sequence generation and concealment. We could not pool the study results statistically as there was heterogeneity in the type of interventions, study design, settings, and outcomes.
The results favoured late patient tracer actions (home visit and letter) compared with no late patient tracer, with reported beneficial effects being both statistically and clinically significant. It is worth noting that the use of letters appeared to be effective in encouraging participants to return to treatment, even in those who were illiterate. There is inadequate evidence to show differences between different types of late patient tracers (ie home visit versus letter).
For reminders, almost all the trials were carried out in the USA except one trial carried out in Spain. There is currently no good quality research evidence on reminders available from developing countries, where the burden of tuberculosis is highest and where the resources available to both health services and patients are different. Two quasi-RCTs, using day of the week as an alternative to randomization, assessed the use of reminders. One was conducted within a screening programme and reminded people to attend for skin test readings, and the other within three different clinics, covering diagnosis, prophylaxis, and treatment. Two RCTs (reported in one paper) used volunteers for a university-sponsored tuberculosis detection drive, while another two assessed the use of reminders in people undergoing a tuberculin skin test and in primary school children who were on tuberculosis chemoprophylaxis, respectively.
The size of trials assessing reminders varied widely from around 50 participants to more than 400 in each group. The risk of bias in the trials was generally low; two were quasi-randomized while the other four were described as randomized, but it was unclear how the allocation sequences were generated and whether the allocation concealment was adequate. None of the trials mentioned whether they took any measures to prevent the control group from receiving the interventions. We could not pool the study results statistically because there was heterogeneity in the types of interventions, study design, settings, and outcomes.
The results of the trials using reminders were varied. In one RCT, within the slightly artificial context of a university-sponsored tuberculosis detection drive, the number of participants returning for Mantoux test reading was no different whether they were given a take-home reminder card or not. In another experiment, carried out at the same place and time, there was no significant difference in return rates between reminders given as a take-home card, a posted card, telephone reminders, or reminders given in person before the participants left the clinic after being given the test, although point estimates were in favour of telephone and person-to-person reminders when compared with written reminders. In two trials (one quasi-randomized) based in real clinic settings, significantly fewer participants missed appointments for skin test reading in the group receiving telephone reminders (including automated telephone reminders). In the other quasi-randomized trial, automated telephone reminders for the diagnosis clinic had no significant effect, but significantly fewer participants from the prophylaxis and treatment clinics who received reminders missed their appointments. In the trial with the co-intervention of health education, significantly fewer participants missed the clinic appointments for tuberculosis chemoprophylaxis.
It is important to note that studies that used bundled interventions were excluded from this review (Thiam 2007) . Excluding studies that used packaged or multiple interventions implemented under programme conditions limits the generalizability of this review. This also highlights the difficulty of doing systematic reviews of trials that test multiple or combined interventions to improve adherence to long-term treatment regimens. Future reviews should consider the implementation of interventions under programme settings. Sustainability and duration of effectiveness of the interventions are other important factors to consider in assessing the effectiveness of healthcare interventions aimed at improving adherence. Strategies to improve patient adherence can be divided into patient-oriented, provider-oriented, and system interventions.
The beneficial effects shown in the trials combining late patient tracers or reminders with additional health education suggest that late patient tracers or reminders may be particularly effective when used in combination with additional education or information for patients. However, the risk of bias in the studies warrants further studies with improved study design. In particular, more attention should be given to the measurement of actual patient outcomes, such as the incidence of active tuberculosis (in prophylaxis studies), tuberculosis cure (in treatment studies), and patient satisfaction.
Almost all the trials were conducted before or during the 1990s, when DOT, short-course (DOTS) was not yet widely practised.
Only one trial was carried out under the DOTS strategy (Mohan 2003) . This trial reported a significant improvement in return for treatment and treatment success in the intervention group (home visit and health education for late patients) compared with usual care, even though the rates of return (82.5%) and treatment success (76.7%) were also quite high in the control group. This suggests that late patient tracer actions may be effective within a good quality DOTS strategy. More studies assessing the use of late patient tracers and reminders under the DOTS strategy are needed.
A Cochrane systematic review of patient reminders and recall systems for improving immunization rates likewise showed that all types of reminders were effective (postcards, letters, telephone, or autodialer calls), with telephone being the most effective but most costly (Vann 2005) . All trials, however, were from developed countries only. On the other hand, the Cochrane systematic review of DOT for tuberculosis showed no significant difference between DOT and self-administered therapy in terms of treatment cure and completion rates (Volmink 2007).
A U T H O R S ' C O N C L U S I O N S Implications for practice
There are different types of late patient tracer actions and reminders being applied to improve adherence to tuberculosis clinic appointments. Despite the limitations of the included studies in terms of type of intervention, methodology, settings, and outcomes, the results show favourable and significantly better outcomes among those patients for whom late patient tracers or reminders are used. Late patient tracers (home visit and letter) are potentially useful in increasing adherence to tuberculosis treatment, and hence improving outcomes for individuals and the community. The results from almost all the reminder trials, except one, show benefits of different types of reminders compared to no reminder on adherence to tuberculosis clinic appointments.
Different types of late patient tracers and reminders can be tailored to suit specific provider and practice needs. Based on current research findings, there is not enough evidence to assess the differences between different types of late patient tracers and reminders. When choosing the type of late patient tracers and reminders, some practical issues also need to be considered, such as staffing, transportation, health facilities, perceived accuracy of patient telephone numbers or addresses, availability of computer programmers, and estimated patient responses to different types of late patient tracers and reminders. Practitioners need to consider their own settings when interpreting the findings in this review since these factors vary widely across nations or geographic regions.
Implications for research
For late patient tracers, more good quality trials are needed to decide the most effective late patient tracer actions in different settings. Any future trials need to record carefully the study design, setting, the details of the intervention, and also the resource implications. More updated trials within the DOTS strategy are needed to confirm the effectiveness of late patient tracers.
For reminders, due to the poor quality of evidence, more welldesigned trials are needed to establish whether reminders are effective in different settings, and the best way of delivering reminders, especially in developing countries. Specifically, future trials should describe carefully the study design, setting, and the details of the intervention, and report primary/clinical health outcomes of the patients. There are no RCTs of reminders carried out in chemoprophylaxis or treatment settings, and considering the importance of adherence to chemoprophylaxis and treatment appointments, such studies would be very useful.
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